+ All Categories
Home > Documents > US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using...

US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using...

Date post: 04-Jun-2020
Category:
Upload: others
View: 4 times
Download: 0 times
Share this document with a friend
28
US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting Workshop on social media FDA, CDER Office of Communications, Division of Drug Information CAPT Catherine Chew, PharmD Deputy Director, Division of Drug Information Kimberly Chiu, PharmD CDER Social Media Lead, Division of Drug Information
Transcript
Page 1: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

US FDA’s Experience with Medicines Communication using Social Media

EMA Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting

Workshop on social media

FDA, CDER Office of Communications, Division of Drug Information

CAPT Catherine Chew, PharmD Deputy Director, Division of Drug Information

Kimberly Chiu, PharmD CDER Social Media Lead, Division of Drug Information

Page 2: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

2

CDER/Office of Communications Center for Drug Evaluation and Research

Office of Communications

Division of Health Communications

Division of Drug Information

Division of Online Communications

Page 3: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

3

Know Your Audience Who is your target audience?

Patients and Consumers

Health Care Providers

Regulated Industry

Page 4: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

4

Know Your Audience What platform(s) does your target audience use?

FDA’s Center for Drug Evaluation and Research

Page 5: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

5

Know Your Audience What platform(s) does your target audience use?

FDA proactively segments twitter audiences

By Product Area (Examples)

Drugs: @FDA_Drug_Info

Biologics: @FDACBER

Tobacco: @FDATobacco

By Audience (Examples)

Patients: @FDA_Patient_Net

Press: @FDAMedia

Devices Industry: @FDACDRHIndustry

Spanish Speakers: @FDA_EnEspanol

By Programs (Examples)

openFDA: @openFDA

PrecisionFDA: @precisionFDA

Page 6: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

6

Page 7: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

7

Know Your Audience What are target audience(s) saying?

– Current concerns or questions – Current misperceptions or incorrect information – Current sentiment

Mentions to FDA

Mentions about FDA

General Mentions

Page 8: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

8

Know Your Tools Best practices

– Graphics and videos increase reach – Best time and how often – Remember mobile devices

Page 9: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

9

Know Your Tools • Identify natural partners

– Stakeholder organizations on social media – Medical information resource companies

Page 10: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

10

Know Your Tools Use metrics to optimize SM platforms

Page 11: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

11

Know Your Tools Use metrics to optimize SM platforms

Page 12: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

12

Know Your Challenges • As a Regulatory Agency:

– Must be neutral – Humanize FDA- “Operation Nice FDA”

• Other Rules, Regulations or Policies

Page 14: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

14

Know Your Challenges

Page 15: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

15

Know Your Challenges

Page 16: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

16

Know Your Challenges

Page 17: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

17

Know Your Challenges

Page 18: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

18

Know Your Challenges Other Rules, Regulations or Policies • Commercial Confidential Information • Paperwork Reduction Act • 508 Compliance • Term of Service (TOS) Agreements

Page 19: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

Social Media as a part of communications strategy

Page 20: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

20

Fluoroquinolones

Page 21: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

21

Social Media Outreach

Page 22: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

22

Listen and Answer

Page 23: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

23

Listen and Answer on Social Media

I experienced an adverse event due to a fluoroquinolone.

How will doctors learn this information?

FDA needs to take more action.

Page 24: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

24

Listen on Stakeholder/Patient Sites

Page 25: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

25

Duchenne Muscular Dystrophy (DMD)

Page 26: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

26

Page 27: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

27

Page 28: US FDA’s Experience with Medicines …...US FDA’s Experience with Medicines Communication using Social Media EMA Human Scientific Committees' Working Parties with Patients’ and

28

(855) 543-3784 or (301) 796-3400 [email protected]

@FDA_DRUG_INFO www.facebook.com/fda

[email protected]

[email protected]

Questions? Comments?


Recommended